Table 1 Demographic, clinical and biochemical characteristics between ACS and SAP group

Age, years

65 (57–71)

65 (57–72)

Male gender, n (%)

136 (67.7%)

83 (57.2%)

Hypertension, n (%)

127 (63.2%)

95 (65.5%)

Diabetes, n (%)

49 (24.4%)

27 (18.6%)

Smoking, n (%)

30 (14.9%)

14 (9.7%)

BMI, kg/m²

24.8 ± 3.3

24.7 ± 3.6

WBC, 10⁹/L

6.7 (5.4–8.1)

5.9 (4.8–6.9)

NEUT, 10⁹/L

4.1 (3.4–5.6)

3.5 (2.7–4.4)

LYM, 10⁹/L

1.7 (1.3–2.1)

1.6 (1.3–2.0)

NLR

2.4 (1.8–3.4)

2.1 (1.7–2.6)

Platelet, 10⁹/L

175 (142–217)

166 (128–203)

RDW

12.8 (12.5–13.4)

13.0 (12.6–13.3)

Hemoglobin, g/L

129.5 ± 16.4

129.2 ± 15.7

IL-6, pg/ml

7.5 (4.8–10.9)

3.8 (2.4–5.3)

hs-CRP, mg/l

6.0 (1.7–11.2)

1.2 (0.5–2.8)

Glucose, mmol/L

5.7 ± 2.3

5.4 ± 1.6

TC, mmol/L

3.9 ± 1.0

3.9 ± 0.9

Triglyceride, mmol/L

1.4 (1.0–1.9)

1.3 (0.9–1.8)

HDL-c, mmol/L

1.2 (1.0–1.4)

1.3 (1.1–1.5)

LDL-c, mmol/L

2.1 (1.6–2.8)

2.1 (1.5–2.7)

apoB, g/L

0.8 (0.6–1.0)

0.8 (0.6–0.9)

apoA1, g/L

1.1 (0.9–1.2)

1.2 (1.0–1.3)

Lp(a), mg/L

227.2 (102.5–469.4)

210.7 (90.5–386.5)

Creatinine, umol/L

69.0 (57.7–85.7)

64.6 (53.7–76.0)

eGFR, ml/min

86.2 (67.6–112.6)

91.4 (66.7–112.9)

Albumin, g/L

39.0 ± 3.4

39.8 ± 3.5

Fibrinogen, g/L

3.0 (2.6–3.9)

2.9 (2.4–3.2)

D-Dimer, ug/ml

0.3 (0.2–0.4)

0.3 (0.2–0.5)

LVEF, %

62.0 (58.0–65.0)

64.0 (60.0–66.0)